Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles W Carroll

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Msphere|May 2, 2022
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other LineagesTessa Prince, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Nature Communications|May 16, 2024
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in GuineaJoseph Akoi Boré, Joseph W S Timothy, Tom Tipton, et al.
Viruses|January 20, 2021
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human InfectionHelen E Everett, Fabian Z X Lean, Alexander M P Byrne, et al.
British Journal of Pharmacology|October 30, 2020
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrationsJulia A Tree, Jeremy E Turnbull, Karen R Buttigieg, et al.
Gigascience|May 31, 2022
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiersXiaofeng Dong, Rebekah Penrice-Randal, Hannah Goldswain, et al.
Viruses|November 2, 2016
Antiviral Screening of Multiple Compounds against Ebola VirusStuart D Dowall, Kevin Bewley, Robert J Watson, et al.
Journal of Clinical Microbiology|March 30, 2021
Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore SequencingLeon Peto, Gillian Rodger, Daniel P Carter, et al.
Plos One|June 17, 2016
Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of InfectionAnthony C Marriott, Mike Dennis, Jennifer A Kane, et al.
Emerging Infectious Diseases|December 22, 2020
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease OutcomesTony Wawina-Bokalanga, Bert Vanmechelen, Valentine Lhermitte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity ReportChris Davis, Tom Tipton, Suleman Sabir, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Msphere|May 2, 2022
Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other LineagesTessa Prince, Xiaofeng Dong, Rebekah Penrice-Randal, et al.
Nature Communications|May 16, 2024
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in GuineaJoseph Akoi Boré, Joseph W S Timothy, Tom Tipton, et al.
Viruses|January 20, 2021
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human InfectionHelen E Everett, Fabian Z X Lean, Alexander M P Byrne, et al.
British Journal of Pharmacology|October 30, 2020
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrationsJulia A Tree, Jeremy E Turnbull, Karen R Buttigieg, et al.
Gigascience|May 31, 2022
Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiersXiaofeng Dong, Rebekah Penrice-Randal, Hannah Goldswain, et al.
Viruses|November 2, 2016
Antiviral Screening of Multiple Compounds against Ebola VirusStuart D Dowall, Kevin Bewley, Robert J Watson, et al.
Journal of Clinical Microbiology|March 30, 2021
Diagnosis of SARS-CoV-2 Infection with LamPORE, a High-Throughput Platform Combining Loop-Mediated Isothermal Amplification and Nanopore SequencingLeon Peto, Gillian Rodger, Daniel P Carter, et al.
Plos One|June 17, 2016
Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of InfectionAnthony C Marriott, Mike Dennis, Jennifer A Kane, et al.
Emerging Infectious Diseases|December 22, 2020
Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease OutcomesTony Wawina-Bokalanga, Bert Vanmechelen, Valentine Lhermitte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2019
Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity ReportChris Davis, Tom Tipton, Suleman Sabir, et al.
Pageof 15